Pfizer 3Q profit falls on generics and higher costs

30-10-2013 Statesman JournalComments (0)


Pfizer Inc.'s third-quarter profit dropped 19 percent as competition from generic drugs continued to cut sales, while lower operating expenses failed to offset higher taxes and charges. Like other drugmakers this quarter, Pfizer said unfavorable ...

Read more on Statesman Journal

More on this story...

Pfizer revenues down as patent losses hit sales

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top